ProCE Banner Activity

DRIVE-FORWARD and DRIVE-AHEAD: Safety and Efficacy of Doravirine in Treatment-Naive Adults at 4 Yr

Slideset Download
Conference Coverage
In combined analysis of open-label extension, maintenance of virologic suppression was demonstrated through 192 weeks.

Released: November 03, 2021

Expiration: November 02, 2022

No longer available for credit.
Begin Activity

Share

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Gilead Sciences, Inc.

Merck Sharp & Dohme Corp.

ViiV Healthcare